HUMA — Humacyte, Inc.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1818382 ·
Last close
$0.65
Market Cap
$176.18M
52W High
$1.52
52W Low
$0.61
ADV30
12,908,938
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 495,000 | -1,543,000 | -28,935,000 | -17,619,000 | 110,557,000 | 48,539,000 | 98,933,000 |
| Dec 2025 | 467,000 | -8,615,000 | -30,836,000 | -24,804,000 | 116,366,000 | 50,497,000 | 113,257,000 |
| Sep 2025 | 753,000 | 493,000 | -24,390,000 | -17,510,000 | 91,509,000 | 19,488,000 | 96,260,000 |
| Jun 2025 | 301,000 | 88,000 | -29,727,000 | -37,658,000 | 138,795,000 | 38,032,000 | 134,743,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-101,545,000
Investing CF
$-831,000
Financing CF
$38,068,000
CapEx
$-831,000
Dividends Paid
$0
Buybacks
—
EPS Diluted TTM
$-0.16
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-744,467,000
Inventory
$9,920,000
Receivables
$434,000
ST Investments
—
EBIT TTM
$-87,070,000
Pretax Income TTM
$-97,591,000
Interest Exp TTM
$10,521,000
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,016,000
EBITDA
$-105,185,000
Free Cash Flow
$-64,806,624
Enterprise Value
$167,070,032
Total Cash
$48,539,000
Total Debt
$66,501,000
Shares Out
269,638,156
Trailing EPS
$-0.63
Book Value
$0.05
ROE
-409.5%
ROA
-51.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,038,000 | -108,137,000 | -40,833,000 | 116,366,000 | 113,257,000 | — | -105,042,000 |
| Dec 2024 | 0 | -114,398,000 | -148,701,000 | 137,872,000 | 190,541,000 | — | -98,122,000 |
| Dec 2023 | 0 | -100,047,000 | -110,776,000 | 128,223,000 | 114,677,000 | — | -73,305,000 |
| Dec 2022 | 0 | -84,578,000 | -11,965,000 | 204,302,000 | 87,374,000 | — | -71,129,000 |
TTM Snapshot
Revenues TTM
$2,255,000
NetIncome TTM
$-122,041,000
OpCashFlow TTM
$0
Assets (Latest)
$137,872,000
Forward EPS
$-0.24
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ACOG | Alpha Cognition Inc. | $180.29M | $8.28 | — |
| DTIL | PRECISION BIOSCIENCES INC | $180.36M | $6.99 | — |
| OTLK | Outlook Therapeutics, Inc. | $182.62M | $0.98 | — |
| VYGR | Voyager Therapeutics, Inc. | $183.08M | $3.03 | — |
| ALEC | Alector, Inc. | $167.65M | $1.51 | — |
News headlines (Yahoo Finance, 1h cache)
Humacyte, Inc. (HUMA) Stock Dips While Market Gains: Key Facts
2026-07-28 22:00 · Yahoo
Humacyte Announces FDA Acceptance of IND for First-In-Human Clinical Study of CTEV for Coronary Artery Bypass Grafting
2026-07-27 12:00 · Yahoo
Humacyte, Inc. (HUMA) Beats Stock Market Upswing: What Investors Need to Know
2026-07-21 22:00 · Yahoo
Humacyte, Inc. (HUMA) Suffers a Larger Drop Than the General Market: Key Insights
2026-07-20 22:15 · Yahoo
Humacyte Appoints Key Nephrologists as Advisors to Prepare for Planned Commercialization of the ATEV in Dialysis Access
2026-07-14 12:00 · Yahoo
Humacyte, Inc. (HUMA) Stock Sinks As Market Gains: Here's Why
2026-06-30 22:00 · Yahoo
Humacyte (HUMA) Stock Fair Value Falls As Split Analyst Views Follow V012 Data
2026-06-27 14:06 · Yahoo
Here's Why Humacyte, Inc. (HUMA) Fell More Than Broader Market
2026-06-25 22:15 · Yahoo
Brokers Suggest Investing in Humacyte, Inc. (HUMA): Read This Before Placing a Bet
2026-06-19 13:30 · Yahoo
Humacyte, Inc. (HUMA) Dips More Than Broader Market: What You Should Know
2026-06-16 22:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.